Article Text

PDF
016 Intraventricular tissue plasminogen activator for the prevention of vasospasm and hydrocephalus after aneurysmal subarachnoid hemorrhage
  1. R Ramakrishna,
  2. L Sekhar,
  3. D Ramanathan,
  4. N Temkin,
  5. D Hallam,
  6. B Ghodke,
  7. L Kim
  1. Neurosurgery, University of Washington, Seattle, Washington, USA

Statistics from Altmetric.com

Introduction: Among the sequelae of aneurysmal SAH are vasospasm and hydrocephalus. This study aims to assess whether intraventricular tissue plasminogen activator (tPA) results in fewer angioplasties and/or CSF shunting procedures.

Methods: 41 patients (group A, Hunt and Hess (HH) 3–5) from 2007 to 2008 received intraventricular tPA and lumbar drainage for a minimum of 5 days (range 5–7 days) and were compared …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.